Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 5
2010 18
2011 36
2012 61
2013 87
2014 112
2015 146
2016 151
2017 132
2018 114
2019 78
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

855 results
Results by year
Filters applied: . Clear all
Page 1
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.
Matanock A, Lee G, Gierke R, Kobayashi M, Leidner A, Pilishvili T. Matanock A, et al. MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1069-1075. doi: 10.15585/mmwr.mm6846a5. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31751323 Free PMC article.
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.
McLaughlin JM, Jiang Q, Isturiz RE, Sings HL, Swerdlow DL, Gessner BD, Carrico RM, Peyrani P, Wiemken TL, Mattingly WA, Ramirez JA, Jodar L. McLaughlin JM, et al. Clin Infect Dis. 2018 Oct 30;67(10):1498-1506. doi: 10.1093/cid/ciy312. Clin Infect Dis. 2018. PMID: 29790925 Free PMC article.
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial.
Goldblatt D, Southern J, Andrews NJ, Burbidge P, Partington J, Roalfe L, Valente Pinto M, Thalasselis V, Plested E, Richardson H, Snape MD, Miller E. Goldblatt D, et al. Lancet Infect Dis. 2018 Feb;18(2):171-179. doi: 10.1016/S1473-3099(17)30654-0. Epub 2017 Nov 22. Lancet Infect Dis. 2018. PMID: 29174323 Free PMC article. Clinical Trial.
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
van Deursen AMM, van Houten MA, Webber C, Patton M, Scott DA, Patterson S, Sidhu M, Drews W, Gruber WC, Emini EA, Grobbee DE, Bonten MJM, Sanders EAM. van Deursen AMM, et al. Clin Infect Dis. 2017 Sep 1;65(5):787-795. doi: 10.1093/cid/cix419. Clin Infect Dis. 2017. PMID: 29017280 Clinical Trial.
Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children.
Ouldali N, Levy C, Minodier P, Morin L, Biscardi S, Aurel M, Dubos F, Dommergues MA, Mezgueldi E, Levieux K, Madhi F, Hees L, Craiu I, Gras Le Guen C, Launay E, Zenkhri F, Lorrot M, Gillet Y, Béchet S, Hau I, Martinot A, Varon E, Angoulvant F, Cohen R. Ouldali N, et al. JAMA Pediatr. 2019 Apr 1;173(4):362-370. doi: 10.1001/jamapediatrics.2018.5273. JAMA Pediatr. 2019. PMID: 30715140 Free PMC article. Clinical Trial.
Efficacy of 13-valent pneumococcal conjugate vaccine in healthcare workers.
Shpagina LA, Kotova OS, Shpagin IS, Loktin EM, Rukavitsyna AA, Kuznetsova GV, Kamneva NV, Laletina MA. Shpagina LA, et al. Ter Arkh. 2018 Nov 22;90(11):55-61. doi: 10.26442/terarkh2018901155-61. Ter Arkh. 2018. PMID: 30701816
855 results
Jump to page
Feedback